º´¿ø¾àÇÐ ¿¬±¸³í¹® °Ë»ö

º´¿ø¾àÇб³À°¿¬±¸¿ø¿¡ ¿À½Å °ÍÀ» ȯ¿µÇÕ´Ï´Ù.
Àüü 44, ÇöÀç 4/5

¼Ò¾Æ ÁßȯÀڽǿ¡¼­ sedation protocol°ú sedation scoring systemÀÇ µµÀÔ°ú ¼º°ú(PICU Medical Team Á¢±Ù)

Á¶¿µÈ¯, ±èÁ¤ÅÂ, ±è½Â¶õ, ¹éÁöÀº, ±è¹Ì°æ(¾Æ»êÀç´Ü ¼­¿ïÁß¾Óº´¿ø ¾àÁ¦ºÎ)
2003 ¤Ó 2004³â Vol.21 No.04

Full Text PDF2003_Á¶¿µÈ¯.pdf

ÁÖ»çÁ¦ Unit Dose SystemÀÇ Æò°¡(Evaluation of unit system for IV medications)

±èÁ¤ÅÂ, À¯¼º±æ, õ¿µÁÖ, Ç㿵¼³
(¼­¿ï¾Æ»êº´¿ø ¾àÁ¦ÆÀ)
2002 ¤Ó 2003³â Vol.20 No.04

Full Text PDF2002_±èÁ¤ÅÂ.pdf

ÇѾà°ú ¾ç¾àÀÇ ¾à¹°»óÈ£ÀÛ¿ë¿¡ °üÇÑ ¿¬±¸- Nicardipine°ú ûÇ÷´ÜÀÇ »óÈ£ÀÛ¿ë -
(Studies on Interactions between Western and Traditional Herbal Medicines(I)
- Effects of CHUNGHYULDAN on the Pharmacokinetics and Pharmacodydnamics of Nicardipine in Rats -)

±è³²Àç, Áø¼º¹Î, ÃÖÇõÀç, ÁÖ¼ö¸¸, ¼Ûº¸¿Ï, ±èÁ¾¿ì
°æÈñÀÇ·á¿ø ¾àÁ¦ºÎ
2001 ¤Ó 2002³â Vol.19 No.04

Full Text PDF2001_±è³²Àç.pdf

Æó°æ±â ¿©¼º¿¡¼­ Ä®½· Á¦Ç°°£ÀÇ »ýüÀÌ¿ë·ü ºñ±³(Comparison of Calcium Bioavailibility of Four Commercial Calcium Supplements in Postmenopausal Women)

¹è¼º¹Ì, ¾ç¼ºÈñ, ÃÖ¼±, ÇÑ¿Á¿¬, ±ÇÇõ»ó*, À±°ÇÈ£*
(°¡Å縯´ëÇб³ °­³²¼º¸ðº´¿ø ¾àÁ¦°ú, ³»°ú*)
2001 ¤Ó 2002³â Vol.19 No.04

Full Text PDF2001_¹è¼º¹Ì.pdf

ȯÀÚ Ãø¸é, º´¿ø¾à»ç Ãø¸é, º´¿ø°æ¿µ Ãø¸é¿¡¼­ º» ¼Ò¾Æ TPNÀÇ À¯¿ë¼º Æò°¡(Drug Use Evaluation of Pediatric TPN Based on Patients, Hospital Pharmacists and Hospital Management)

±è±Í¼÷(¼­¿ï´ëÇб³º´¿ø ¾àÁ¦ºÎ)
2000 ¤Ó 2001³â Vol.18 No.04

Full Text PDF2000_±è±Í¼÷.pdf

polysulfone Åõ¼®¸·À¸·Î Ç÷¾×Åõ¼®Çϴ ȯÀÚ¿¡¼­ÀÇ VancomycineÀÇ Á¦°Å¿¡ °üÇÑ ¿¬±¸(Vancomycin Removal During Hemodialysis Using a Polysulfone Membrane)

±èº¸¿µ, ÀÌÇöÁÖ(°í·Á´ëÇб³ÀÇ·á¿ø ¾È¾Ïº´¿ø ¾àÁ¦°ú)
2000 ¤Ó 2001³â Vol.18 No.04

Full Text PDF2000_±èº¸¿µ.pdf

Á¶Á¦,º¹¾àÁöµµ ¾÷¹«ÀÇ ÁúÇâ»ó ÁöÇ¥ ¹× Á¡°Ë ¾ç½Ä °³¹ß(Developing of Indicators and Inspection Records for Quality Assurance in Medication and Patient Education in Pharmacy Department)

À̺´±¸, À̼ø½Ç, ±è¿µÁÖ, ±è°æÈñ, ·ùÀ±¹Ì ¼­¿ï´ëÇб³º´¿ø ¾àÁ¦ºÎ
1999 ¤Ó 2001³â Vol.18 No.01

Full Text PDF1999_À̺´±¸.pdf

°ñ¼ö À̽Ľà Cyclosporine°ú °°Àº °æ·Î·Î Åõ¿©µÇ´Â ¾à¹°ÀÇ »óÈ£ÀûÇÕ¼º¿¡ °üÇÑ ¿¬±¸ (The Compatibility of Cyclosporine with Commonly Used IV Drugs in BMT Unit During Y-site Delivery)

Á¤°æÁÖ, Ãֽ±â*(Æ÷õÁß¹®ÀÇ°ú´ëÇб³ ºÐ´çÂ÷º´¿ø ¾àÁ¦ºÎ, ¾à¸®ÇÐ ±³½Ç*)
1999 ¤Ó 2001³â Vol.18 No.01

Full Text PDF1999_Ãֽ±â.pdf

TPN ó¹æ ½Ã½ºÅÛÀ» ÀÌ¿ëÇÑ ¾à±¹ ¾÷¹« °³¼±(TPN Order System for the Improvement of Pharmacy Affairs)

Á¶¿µÈ¯, ±èÁ¤ÅÂ, ±è½Â¶õ, ¹éÁöÀº, ±è¹Ì°æ (¾Æ»êÀç´Ü ¼­¿ïÁß¾Óº´¿ø ¾àÁ¦ºÎ)
1998 ¤Ó 2000³â Vol.17 No.01

Full Text PDF1998_Á¶¿µÈ¯.pdf

Çѱ¹ÀΠȯÀÚ¿¡ À־ÀÇ AminoglycosideÀÇ ¾àµ¿ÇÐ ÀڷḦ ÀÌ¿ëÇÑ VancomycineÀÇ ¾àµ¿ÇÐ º¯¼ö ¿¹Ãø(Prediction of Vancomycin Pharmacokinetics Using Aminoglycoside Pharmacokinetic Parameters in Korean Patients)

ÀÓÇöÁ¤, Á¤ÁöÀº, ¼­¿Á°æ, ÃÖ°æ¾÷(»ï¼º¼­¿ïº´¿ø ¾àÁ¦ºÎ)
1998 ¤Ó 2000³â Vol.17 No.01

Full Text PDF1998_ÃÖ°æ¾÷.pdf